Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Ferrari
Paolo
P
D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2; D000818:Animals; D065128:Endothelin Receptor Antagonists; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006034:Glycyrrhetinic Acid / Q000494:pharmacology; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control*; D009569:Nitric Oxide / Q000502:physiology*; D051381:Rats; D044022:Receptor, Endothelin A; D014652:Vascular Diseases / Q000139:chemically induced / Q000517:prevention & control
D065128:Endothelin Receptor Antagonists; D004791:Enzyme Inhibitors; D044022:Receptor, Endothelin A; D009569:Nitric Oxide; D006913:Hydroxysteroid Dehydrogenases; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2; D006034:Glycyrrhetinic Acid